Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for RENVELA
- A Phase 2 Study to Evaluate the Safety and Efficacy of VS-505 to Treat Hyperphosphatemia in Hemodialysis Patients
- Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
- GLP-1-mediated Gluco-metabolic Effects of Bile Acid Sequestration
- PA21 Safety and Efficacy in Adult Chinese Subjects
- A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on Dialysis
- Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China
- A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
- A Phase 1 Study to Examine the Effect of Renvela on the Pharmacodynamics of AZD1722
- An Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic CKD Patients
- Optimal Anemia Treatment in End Stage Renal Disease (ERSD)
- Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2)
- Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1)
- Post Authorisation Safety Study of Renvela® in Chronic Kidney Disease Patients Not on Dialysis With Hyperphosphataemia
- Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on Hemodialysis
- Sevelamer for Reducing Endotoxemia and Immune Activation
- The Effects of Sevelamer Carbonate on Diabetic Nephropathy
- Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
- Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney Disease
- Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4
- The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan
- Treatment of Early Stage Renal Failure With Active Vitamin D or a Phosphate Binder.
- A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis
- A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
- FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease
- The Pharmacokinetics of Rocaltrol When Administered Alone or in Combination With Fosrenol or Renvela in Healthy Volunteers
- Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult Volunteers
- Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on Hemodialysis
- A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD
Clinical trials list
click for details